A detailed history of Exodus Point Capital Management, LP transactions in Orasure Technologies Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 15,260 shares of OSUR stock, worth $60,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,260
Previous 101,891 85.02%
Holding current value
$60,582
Previous $434,000 85.02%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.93 - $4.59 $340,459 - $397,636
-86,631 Reduced 85.02%
15,260 $65,000
Q2 2024

Aug 13, 2024

SELL
$4.2 - $6.18 $200,277 - $294,693
-47,685 Reduced 31.88%
101,891 $434,000
Q1 2024

May 14, 2024

BUY
$6.08 - $8.28 $794,236 - $1.08 Million
130,631 Added 689.53%
149,576 $920,000
Q3 2023

Nov 09, 2023

SELL
$4.4 - $6.91 $245,212 - $385,094
-55,730 Reduced 74.63%
18,945 $112,000
Q2 2023

Aug 10, 2023

BUY
$4.88 - $7.39 $364,414 - $551,848
74,675 New
74,675 $374,000
Q3 2022

Nov 10, 2022

SELL
$2.72 - $4.61 $630,898 - $1.07 Million
-231,948 Reduced 89.28%
27,850 $106,000
Q2 2022

Aug 19, 2022

BUY
$2.71 - $7.12 $704,052 - $1.85 Million
259,798 New
259,798 $704,000
Q1 2021

May 17, 2021

SELL
$9.53 - $15.42 $254,574 - $411,914
-26,713 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$10.35 - $15.94 $276,479 - $425,805
26,713 New
26,713 $283,000
Q2 2020

Aug 14, 2020

SELL
$9.71 - $17.87 $297,126 - $546,822
-30,600 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$5.57 - $10.76 $170,442 - $329,256
30,600 New
30,600 $329,000
Q4 2019

Feb 14, 2020

SELL
$7.21 - $8.89 $90,759 - $111,907
-12,588 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$6.57 - $9.46 $1,576 - $2,270
240 Added 1.94%
12,588 $94,000
Q2 2019

Aug 14, 2019

BUY
$8.17 - $11.07 $100,883 - $136,692
12,348 New
12,348 $115,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $288M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.